FIVE vs JAZZ · P/E 28, rev $1.39B vs P/E 1988, rev $4.07B
Five Below Inc (FIVE) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
FIVE currently screens at market cap $7.30B and trailing P/E 27.7. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the FIVE and JAZZ stock pages for the full models.
Not investment advice.